Dataset from A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination With Methotrexate (MTX) to Subjects With Moderately to Severely Active Rheumatoid Arthritis Who Are Naïve to MTX Therapy
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008707
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of this study is to evaluate the effects of filgotinib in combination
with methotrexate (MTX) versus MTX alone in adults with active rheumatoid arthritis (RA).
创建时间：
2025-08-21
